D R Lohmann1, B Brandt, U Oehlschläger
1Institut für Humangenetik, Universitätsklinikum Essen, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Molecular analysis aids retinoblastoma management by assessing familial and sporadic disease risks. New rapid mutation screening methods improve carrier risk assessment for hereditary retinoblastoma (RB1) mutations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: